Interspinous implants or spacers are proposed for stabilization or distraction of the adjacent lamina or spinous processes and for arresting the extension for pain reduction in patients with lumbar spinous stenosis and other such conditions. These are small devices implanted in the spinous processes to provide dynamic stabilization as an alternative to decompressive surgery or following decompressive surgery. The high prevalence of degenerative spinal conditions caused by aging, as well as the benefits offered, such as the lower risk of infection due to less blood loss, less downtime, and motion preservation, are driving the global market growth for interspinous spacers.
Static spacers for lumbar spinal stenosis treatment to urge market growth
The global interspinous spacers market is segmented on the basis of product types, applications, and geographical demarcation. Based on products, static (compressible) spacers dominate the global market and shall retain their lead through the forecast period. Evidence suggests that static interspinous spacers are the most cost-effective alternative to laminectomy in patients with lumbar spinal stenosis. Dynamic (non-compressible) spacer segments shall progress at a stable rate due to better therapeutic benefits and lower failure rates.
Among the applications, lumbar spinal stenosis (LSS) is the most prominent area experiencing the largest adoption of interspinous spacers. LSS is the narrowing of the spinal canal and can either be congenital or acquired. With an aging population, this condition is becoming more prevalent. Conventional treatment for LSS involves posture correction, muscle strengthening, and epidural injections. However, due to the degenerative nature of LSS, conventional treatments lack complete efficacy, therefore urging the need for surgical intervention. Interspinous stabilizers are a relatively new addition to surgical intervention. It is clinically reported that interspinous devices offer a simple, cost-effective, minimally invasive alternative to standard procedures for the treatment of LSS. The latest generation of interspinous spacers also offers stand-alone functionality, therefore not requiring additional procedures for decompression.
Asia Pacific will witness rapid growth with increasing procedure rates.
Geographically, North America is the largest regional market for interspinous spacers. High adoption rates of new technologies and the earliest introduction of interspinous spacers in the U.S. market characterize the dominance of North America. Moreover, the U.S. market is also witnessing a strong product pipeline, with the consequent anticipation of next-generation products in the region. Asia Pacific, on the other hand, will experience rapid market growth during the forecast period. Rapidly evolving healthcare infrastructure, growing healthcare expenditure, improving reimbursements, and the skills of surgeons are the chief attributes of the fast-moving Asia-Pacific market. Growing geriatric populations in China, Japan, and India are also urging significant market movements.
Periods of History and Forecast
This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
The interspinous spacers market report provides a quantitative assessment of the industry in terms of current and forecasted market size while also presenting the market dynamics. This market is segmented based on types and geography.
This report also includes a company profiles section that gives insights into the company overview, product portfolio, financial information, and key developments of major market players. The major players profiled in this report include Medtronic plc, Zimmer Biomet, NuVasive, Inc., Life Spine, Inc., RTI Surgical Holdings, Inc. (Paradigm Spine LLC), Vertiflex, Inc., Globus Medical, Inc., Synthes GmbH (DePuy Synthes), Mikai S.p.A., and Alphatec Spine, Inc.
Key questions are answered in this report.
What is the estimated size of the global interspinous spacer market during the period from 2026 to 2026?
What are the key factors determining the demand for interspinous spacers globally?
Which are the major pain points currently evident in the market that restrain market growth?
Which type of interspinous spacer is anticipated to dominate the global market?
Which application area will witness the fastest adoption of interspinous implants during the forecast period?
What are the key factors driving the growth of the Asia-Pacific market?
Frequently Asked Questions:
The market for Interspinous Spacers Market is expected to reach US$ XX Mn by 2026.
The Interspinous Spacers Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2018-2026.
The base year of this report is 2017.
Zimmer Biomet, NuVasive, Inc., Life Spine, Inc., RTI Surgical Holdings, Inc. (Paradigm Spine LLC), Vertiflex, Inc., Globus Medical, Inc., Synthes GmbH (DePuy Synthes), Mikai S.p.A are some of the major players in the global market.
